ArticlePatient preference and adherence2023

Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis.

Alan Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.